Bandwidth (BAND) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Bandwidth (NASDAQ: BAND): 11/11/2026 – Bandwidth had its “buy” rating reaffirmed by Needham & Company LLC. 11/4/2026 – Bandwidth was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”. 10/31/2026 – Bandwidth was upgraded by Wall Street Zen from “hold” to “buy”. 10/30/2026 […]
Investment Analysts’ Weekly Ratings Changes for 3M (MMM)
A number of firms have modified their ratings and price targets on shares of 3M (NYSE: MMM) recently: 11/5/2026 – 3M had its price target raised by The Goldman Sachs Group from $200.00 to $225.00. They now have a “buy” rating on the stock. 11/4/2026 – 3M was given a new $230.00 price target by […]
Qualcomm (QCOM) – Investment Analysts’ Weekly Ratings Changes
Qualcomm (NASDAQ: QCOM) recently received a number of ratings updates from brokerages and research firms: 11/9/2026 – Qualcomm was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”. 11/9/2026 – Qualcomm was downgraded by Freedom Broker from “buy” to “hold”. They now have a $185.00 price target on the stock, down from $200.00. 11/5/2026 […]
Recent Investment Analysts’ Ratings Changes for Aztar (AZR)
Aztar (NASDAQ: AZR) recently received a number of ratings updates from brokerages and research firms: 11/10/2026 – Aztar was downgraded by Wall Street Zen from “sell” to “strong sell”. 11/2/2026 – Aztar was upgraded by Wall Street Zen to “sell”. 11/2/2026 – Aztar is now covered by JonesTrading. They set a “buy” rating and a […]
Investment Analysts’ Weekly Ratings Changes for MidCap Financial Investment (MFIC)
Several analysts have recently updated their ratings and price targets for MidCap Financial Investment (NASDAQ: MFIC): 11/4/2026 – MidCap Financial Investment had its “sell (d+)” rating reaffirmed by Weiss Ratings. 11/2/2026 – MidCap Financial Investment was downgraded by Truist Financial from “buy” to “hold”. They now have a $11.00 price target on the stock, down […]
Investment Analysts’ Weekly Ratings Changes for ARM (ARM)
A number of research firms have changed their ratings and price targets for ARM (NASDAQ: ARM): 11/5/2026 – ARM had its price target lowered by TD Cowen from $350.00 to $250.00. They now have a “buy” rating on the stock. 11/5/2026 – ARM had its price target lowered by Royal Bank Of Canada from $340.00 […]
Investment Analysts’ Weekly Ratings Changes for Revolution Medicines (RVMD)
A number of research firms have changed their ratings and price targets for Revolution Medicines (NASDAQ: RVMD): 11/6/2026 – Revolution Medicines had its price target raised by HC Wainwright from $280.00 to $350.00. They now have a “buy” rating on the stock. 11/5/2026 – Revolution Medicines had its price target raised by TD Cowen from […]
Ovintiv (OVV) – Investment Analysts’ Recent Ratings Changes
Ovintiv (NYSE: OVV) has recently received a number of price target changes and ratings updates: 11/5/2026 – Ovintiv had its price target raised by Truist Financial from $77.00 to $90.00. They now have a “buy” rating on the stock. 11/5/2026 – Ovintiv had its price target lowered by Wells Fargo & Company from $82.00 to […]
Plumas Bancorp (PLBC) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Plumas Bancorp (NASDAQ: PLBC): 10/24/2026 – Plumas Bancorp was upgraded by Wall Street Zen from “hold” to “buy”. 10/23/2026 – Plumas Bancorp was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”. 10/21/2026 – Plumas Bancorp was given a new $70.00 price target […]
Recent Investment Analysts’ Ratings Changes for Northern Oil and Gas (NOG)
Northern Oil and Gas (NYSE: NOG) recently received a number of ratings updates from brokerages and research firms: 10/30/2026 – Northern Oil and Gas was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”. 10/28/2026 – Northern Oil and Gas had its “outperform” rating reaffirmed by Raymond James Financial. They now have a $34.00 […]
Realty Income (O) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Realty Income (NYSE: O): 11/3/2026 – Realty Income had its price target raised by Royal Bank Of Canada from $60.00 to $61.00. They now have an “outperform” rating on the stock. 11/2/2026 – Realty Income is now covered by Huntington. They set a “strong-buy” […]
Investment Analysts’ Weekly Ratings Changes for SL Green Realty (SLG)
SL Green Realty (NYSE: SLG) has recently received a number of price target changes and ratings updates: 11/2/2026 – SL Green Realty had its price target lowered by Wells Fargo & Company from $56.50 to $54.00. They now have an “equal weight” rating on the stock. 10/27/2026 – SL Green Realty had its price target […]
United Dominion Realty Trust (UDR) – Investment Analysts’ Weekly Ratings Changes
A number of firms have modified their ratings and price targets on shares of United Dominion Realty Trust (NYSE: UDR) recently: 11/4/2026 – United Dominion Realty Trust had its price target raised by Royal Bank Of Canada from $37.00 to $38.00. They now have a “sector perform” rating on the stock. 10/19/2026 – United Dominion […]
International Flavors & Fragrances (IFF) – Investment Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of International Flavors & Fragrances (NYSE: IFF) in the last few weeks: 10/25/2026 – International Flavors & Fragrances was upgraded by Wall Street Zen from “sell” to “hold”. 10/22/2026 – International Flavors & Fragrances had its price target raised by Oppenheimer from $95.00 to […]
Recent Investment Analysts’ Ratings Changes for Dave (DAVE)
A number of firms have modified their ratings and price targets on shares of Dave (NASDAQ: DAVE) recently: 10/31/2026 – Dave was downgraded by Wall Street Zen from “hold” to “sell”. 10/30/2026 – Dave was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”. 10/26/2026 – Dave is now covered by Monness Crespi & […]
Veradermics (MANE) – Investment Analysts’ Recent Ratings Changes
Several analysts have recently updated their ratings and price targets for Veradermics (NYSE: MANE): 10/22/2026 – Veradermics was given a new $204.00 price target by UBS Group. 10/22/2026 – Veradermics had its price target raised by B. Riley Financial from $170.00 to $204.00. They now have a “buy” rating on the stock. 10/19/2026 – Veradermics […]
Tango Therapeutics (TNGX) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Tango Therapeutics (NASDAQ: TNGX): 10/29/2026 – Tango Therapeutics had its “buy” rating reaffirmed by HC Wainwright. They now have a $68.00 price target on the stock. 10/27/2026 – Tango Therapeutics was downgraded by Zacks Research from “hold” to “strong sell”. 10/23/2026 – Tango Therapeutics […]
last updated on 16 Nov 20:22